|
Scientific Plenary V: Bullseye! Precision Medicine and Hitting the Right Targets |
|
Enduring |
|
$0.00 |
|
Turnover Talk: Molecular Testing and Patient Selection in Ovarian Cancer |
|
Enduring |
|
$0.00 |
|
SGO Wellness Curriculum Sneak Peek Part 1: Managing Priorities |
|
Enduring |
|
$0.00 |
|
Enhanced Recovery: The New Standard for Perioperative Care in Gynecologic Oncology: Implementing ERAS, the Nuts and Bolts |
|
Enduring |
|
$0.00 |
|
Keeping up with the Chemos Series: Tisotumab Vedotin - Follow up Monitoring Between Cycles (Part 3) |
|
Enduring |
|
$0.00 |
|
Eradicating Racism and Discrimination in Medicine (Session from SGO 2021 Annual Meeting) |
|
Enduring |
|
$0.00 |
|
SGO Journal Club: Controversial Topics in Gynecologic Cancer: Heated Intraperitoneal Chemotherapy |
|
Enduring |
|
$0.00 |
|
Keeping up with the Chemos Series on Trastuzumab Deruxtecan ENHERTU®: Preparing to Give It (Pt. 1) |
|
Enduring |
|
$0.00 |
|
Keeping up with the Chemos Series: Lenvatinib/Pembrolizumab - Preparing to Give It (Part 1) |
|
Enduring |
|
$0.00 |
|
2021 Oral Featured Poster Sessions |
|
Enduring |
|
$0.00 |
|
Session 3: Barriers to Care |
|
Enduring |
|
$0.00 |
|
Turnover Talk: Allied Health Lynch Syndrome |
|
Enduring |
|
$0.00 |
|
The Future is Now: Determining the Fate of Gynecologic Oncology |
|
Enduring |
|
$0.00 |
|
Scientific Plenary III: Novel Therapeutics: The Expanding Toolbox |
|
Enduring |
|
$0.00 |
|
Turnover Talk: Novel Discoveries in Endometrial Cancer: Are we finally making progress? |
|
Enduring |
|
$0.00 |
Facebook
Twitter
LinkedIn
Forward